The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global ED Treatment Market Research Report 2024
Synopsis
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global ED Treatment market was valued at US$ 4885 million in 2023 and is anticipated to reach US$ 7345.1 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ED Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ED Treatment.
Report Scope
The ED Treatment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ED Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ED Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospitals
Drugstores
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ED Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ED Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.
The global ED Treatment market was valued at US$ 4885 million in 2023 and is anticipated to reach US$ 7345.1 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ED Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ED Treatment.
Report Scope
The ED Treatment market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ED Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ED Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospitals
Drugstores
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of ED Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of ED Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 ED Treatment Market Overview
1.1 Product Overview and Scope of ED Treatment
1.2 ED Treatment Segment by Type
1.2.1 Global ED Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Sildenafil
1.2.3 Tadalafil
1.2.4 Others
1.3 ED Treatment Segment by Application
1.3.1 Global ED Treatment Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Other
1.4 Global ED Treatment Market Size Estimates and Forecasts
1.4.1 Global ED Treatment Revenue 2019-2030
1.4.2 Global ED Treatment Sales 2019-2030
1.4.3 Global ED Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 ED Treatment Market Competition by Manufacturers
2.1 Global ED Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global ED Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global ED Treatment Average Price by Manufacturers (2019-2024)
2.4 Global ED Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of ED Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of ED Treatment, Product Type & Application
2.7 ED Treatment Market Competitive Situation and Trends
2.7.1 ED Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest ED Treatment Players Market Share by Revenue
2.7.3 Global ED Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 ED Treatment Retrospective Market Scenario by Region
3.1 Global ED Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global ED Treatment Global ED Treatment Sales by Region: 2019-2030
3.2.1 Global ED Treatment Sales by Region: 2019-2024
3.2.2 Global ED Treatment Sales by Region: 2025-2030
3.3 Global ED Treatment Global ED Treatment Revenue by Region: 2019-2030
3.3.1 Global ED Treatment Revenue by Region: 2019-2024
3.3.2 Global ED Treatment Revenue by Region: 2025-2030
3.4 North America ED Treatment Market Facts & Figures by Country
3.4.1 North America ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America ED Treatment Sales by Country (2019-2030)
3.4.3 North America ED Treatment Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe ED Treatment Market Facts & Figures by Country
3.5.1 Europe ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe ED Treatment Sales by Country (2019-2030)
3.5.3 Europe ED Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific ED Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific ED Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific ED Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America ED Treatment Market Facts & Figures by Country
3.7.1 Latin America ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America ED Treatment Sales by Country (2019-2030)
3.7.3 Latin America ED Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa ED Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa ED Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa ED Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa ED Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global ED Treatment Sales by Type (2019-2030)
4.1.1 Global ED Treatment Sales by Type (2019-2024)
4.1.2 Global ED Treatment Sales by Type (2025-2030)
4.1.3 Global ED Treatment Sales Market Share by Type (2019-2030)
4.2 Global ED Treatment Revenue by Type (2019-2030)
4.2.1 Global ED Treatment Revenue by Type (2019-2024)
4.2.2 Global ED Treatment Revenue by Type (2025-2030)
4.2.3 Global ED Treatment Revenue Market Share by Type (2019-2030)
4.3 Global ED Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global ED Treatment Sales by Application (2019-2030)
5.1.1 Global ED Treatment Sales by Application (2019-2024)
5.1.2 Global ED Treatment Sales by Application (2025-2030)
5.1.3 Global ED Treatment Sales Market Share by Application (2019-2030)
5.2 Global ED Treatment Revenue by Application (2019-2030)
5.2.1 Global ED Treatment Revenue by Application (2019-2024)
5.2.2 Global ED Treatment Revenue by Application (2025-2030)
5.2.3 Global ED Treatment Revenue Market Share by Application (2019-2030)
5.3 Global ED Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Eli Lilly ED Treatment Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer ED Treatment Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer ED Treatment Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 BaiYunShan General Factory
6.4.1 BaiYunShan General Factory Corporation Information
6.4.2 BaiYunShan General Factory Description and Business Overview
6.4.3 BaiYunShan General Factory ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BaiYunShan General Factory ED Treatment Product Portfolio
6.4.5 BaiYunShan General Factory Recent Developments/Updates
6.5 S.K. Chemicals
6.5.1 S.K. Chemicals Corporation Information
6.5.2 S.K. Chemicals Description and Business Overview
6.5.3 S.K. Chemicals ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 S.K. Chemicals ED Treatment Product Portfolio
6.5.5 S.K. Chemicals Recent Developments/Updates
6.6 Teva Pharma
6.6.1 Teva Pharma Corporation Information
6.6.2 Teva Pharma Description and Business Overview
6.6.3 Teva Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharma ED Treatment Product Portfolio
6.6.5 Teva Pharma Recent Developments/Updates
6.7 Dong-A ST
6.6.1 Dong-A ST Corporation Information
6.6.2 Dong-A ST Description and Business Overview
6.6.3 Dong-A ST ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dong-A ST ED Treatment Product Portfolio
6.7.5 Dong-A ST Recent Developments/Updates
6.8 Metuchen Pharma
6.8.1 Metuchen Pharma Corporation Information
6.8.2 Metuchen Pharma Description and Business Overview
6.8.3 Metuchen Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Metuchen Pharma ED Treatment Product Portfolio
6.8.5 Metuchen Pharma Recent Developments/Updates
6.9 Seoul Pharma
6.9.1 Seoul Pharma Corporation Information
6.9.2 Seoul Pharma Description and Business Overview
6.9.3 Seoul Pharma ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Seoul Pharma ED Treatment Product Portfolio
6.9.5 Seoul Pharma Recent Developments/Updates
6.10 CSBIO.
6.10.1 CSBIO. Corporation Information
6.10.2 CSBIO. Description and Business Overview
6.10.3 CSBIO. ED Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 CSBIO. ED Treatment Product Portfolio
6.10.5 CSBIO. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 ED Treatment Industry Chain Analysis
7.2 ED Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 ED Treatment Production Mode & Process
7.4 ED Treatment Sales and Marketing
7.4.1 ED Treatment Sales Channels
7.4.2 ED Treatment Distributors
7.5 ED Treatment Customers
8 ED Treatment Market Dynamics
8.1 ED Treatment Industry Trends
8.2 ED Treatment Market Drivers
8.3 ED Treatment Market Challenges
8.4 ED Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
